+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Role of vitamin D in improvement in changes of podocyte P-cadherin/β-catenin complex induced by diabetic conditions



Role of vitamin D in improvement in changes of podocyte P-cadherin/β-catenin complex induced by diabetic conditions



Iranian Journal of Kidney Diseases 9(3): 194-201



This study aimed to investigate the effect of vitamin D on the pathologic changes of podocyte β-catenin and P-cadherin and podocyte permeability induced by diabetic conditions. We cultured mouse podocytes under normal glucose (5 mM, control); high glucose (HG, 30 mM); advanced glycosylation end products (AGE)-added; and HG plus AGE-added conditions and treated with vitamin D. The distribution of podocyte β-catenin and P-cadherin was shown by confocal microscopy, and protein levels of β-catenin and P-cadherin by Western blotting. Podocytes were incubated with vitamin D at the concentrations of 10 nM and 50 nM for 6, 24, and 48 hours. The dextran filtration through monolayered podocytes tended to increase in AGE and HG condition compared to that in B5 at 16 hours in permeability assay, which was improved by vitamin D. In confocal imaging, the distribution of β-catenin and P-cadherin were internally concentrated by diabetic conditions, which was ameliorated by vitamin D. In Western blotting, HG and AGE decreased β-catenin protein levels at 6, 24, and 48 hours and vitamin D improved the decreased β-catenin protein levels at 6, 24, and 48 hours. Advanced glycosylation end products also decreased P-cadherin protein amount by 22.9% and 59.1% (P <.01) at 24 hours, respectively, which was improved by vitamin D. Our results suggest that HG and AGE have an influence on the redistribution of β-catenin and P-cadherin and amount of β-catenin protein of podocytes, thereby causing hyperpermeability, which can be reversed by vitamin D.

(PDF emailed within 1 workday: $29.90)

Accession: 058791812

Download citation: RISBibTeXText

PMID: 25957423


Related references

The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats. Molecular and Cellular Biochemistry 399(1-2): 155-165, 2015

Evidence that the V832M E-cadherin germ-line missense mutation does not influence the affinity of alpha -catenin for the cadherin/catenin complex. Cell Communication and Adhesion 14(2-3): 45-55, 2007

Motogen induced dissociation of the E-cadherin/catenin complex and association of beta-catenin with signal transduction pathways in prostate cancer cells. British Journal of Cancer 85(Supplement 1): 86, 2001

Modulation of E-cadherin expression in TPA-induced cell motility: well-differentiated human adenocarcinoma cells move as coherent sheets associated with phosphorylation of E-cadherin-catenin complex. Laboratory Investigation; A Journal of Technical Methods and Pathology 76(1): 139-151, 1997

Presenilin-1 binds cytoplasmic epithelial cadherin, inhibits cadherin/p120 association, and regulates stability and function of the cadherin/catenin adhesion complex. Proceedings of the National Academy of Sciences of the United States of America 98(5): 2381-2386, 2001

Matrix metalloproteinase(s) mediate(s) NO-induced dissociation of beta-catenin from membrane bound E-cadherin and formation of nuclear beta-catenin/LEF-1 complex. Carcinogenesis 23(12): 2119-2122, 2002

Matrix metalloproteinase(s) mediate(s) NO-induced dissociation of beta-catenin from membrane bound E-cadherin and formation of nuclear beta-catenin/LEF-1 complex. Carcinogenesis 23(12): 2119-2122, 2003

Matrix metalloproteinase mediate NO-induced dissociation of beta-catenin from membrane bound E-cadherin and formation of the nuclear beta-catenin/LEF-1 complex. FASEB Journal 15(5): A933, March 8, 2001

LncRNA MALAT1 is dysregulated in diabetic nephropathy and involved in high glucose-induced podocyte injury via its interplay with β-catenin. Journal of Cellular and Molecular Medicine 21(11): 2732-2747, 2017

Structure of the E-cadherin/catenin complex Functional domains of beta-catenin involved in complex formation. European Journal of Cell Biology 63(SUPPL 40): 70, 1994

The role of E-cadherin/catenin complex in laryngeal cancer. Experimental Oncology 27(4): 257-261, 2006

The role of the E-cadherin/catenin complex in gastric cancer. Gastroenterology 118(4 Suppl 2 Part 1): AGA A512, 2000

The role of the E-cadherin/catenin complex in gastrointestinal cancer. Acta Gastro-Enterologica Belgica 62(4): 393-402, 2000

The role of E-cadherin-catenin complex: more than an intercellular glue?. Annals of Surgical Oncology 7(10): 783-788, 2000

The role of cadherin/catenin complex in malignant melanoma. Experimental Oncology 28(3): 187-193, 2006